Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis.

Qixing, Mao

Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis. [electronic resource] - Medicine Sep 2015 - e1593 p. digital

Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review

1536-5964

10.1097/MD.0000000000001593 doi


DNA-Binding Proteins--genetics
Endonucleases--genetics
Esophageal Neoplasms--mortality
Humans
Lung Neoplasms--mortality
Neoadjuvant Therapy
Polymorphism, Single Nucleotide
Survival Analysis
Xeroderma Pigmentosum Group D Protein--genetics